CClinicalTrials.gg
CompletedNCT05006027SEVEN-BOXUpdated Nov 25, 2025

Feasibility of PCI Using a 7-Fr Thin-Walled Sheath Via the DRA

An observational study in Coronary Artery Disease, Distal Radial Artery and Complex Intervention, sponsored by Yonsei University. Completed at 2 sites in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2025-11-25.

Sponsored by Yonsei University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
19 Years and older
Sex
All
01

Study summary

To evaluate the safety and effectiveness of percutaneous coronary intervention using a 7-French(Fr) thin-walled sheath via the distal radial approach

Read the detailed description

Recently, coronary angiography (CAG) and percutaneous coronary intervention (PCI) via the distal radial artery access (DRA) have shown several advantages owing to fewer complications, such as radial artery occlusion, pseudoaneurysms, and arteriovenous(AV) fistulas, and short hemostasis duration than the proximal radial access (PRA). However, despite the potential advantages of the DRA, there are still many cardiologists who prefer the femoral approach for complex PCI including left main disease, bifurcation lesions, heavily calcified lesions, which need a strong backup and using several devices. The radial artery and the distal radial artery have a smaller diameter than the femoral artery, and interventional cardiologists are usually performed using the 6-Fr sheath. The previously developed 7-Fr sheath has a higher risk of vascular occlusion when use in a radial artery due to larger diameter compared to radial artery in 30% to 60% of patients. However, with the recent development of various technologies, the outer diameter of the sheath is gradually becoming thinner and recently a 7-Fr thin-walled sheath which does not differ significantly from the outer diameter of the 6-Fr sheath used in the previously PRA demonstrated that feasibility and safety for radial artery intervention. Despite the feasibility and potential benefits of the DRA and 7-Fr thin-walled sheath for radial artery, there is a lack of data regarding the safety and efficacy of a 7-Fr thin-walled sheath during the DRA.

02

Conditions studied

  • Coronary Artery Disease
  • Distal Radial Artery
  • Complex Intervention

Keywords

  • distal radial artery
  • coronary artery disease
  • percutaneous coronary intervention
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 100 is below the median of 336 across 1,947 observational studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Yonsei University is the lead sponsor of 1,387 studies on the registry; 232 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

patients with coronary artery disease who planned to perform PCI using a 7-Fr thin-walled sheath will be recruited

Inclusion criteria

  • Patients, ≥ 19 years of age, who were diagnosed with ischemic heart disease requiring percutaneous coronary intervention (PCI)
  • Patients who are palpable distal radial artery
  • The decision to participate voluntarily in this study and the written consent of the patient
  • Patients who planned to perform PCI using a 7-Fr thin-walled sheath

Exclusion criteria

Exclusion Criteria:

  • Patients who are not palpable distal radial artery
  • Female of childbearing potential, who possibly plans to become pregnant any time after enrollment into this study
  • Pregnancy
  • Patients who are not appropriate for this study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Target follow-up
1 Month
Patient registry
Yes

Groups and cohorts

  • Percutaneous coronary intervention using a 7-Fr thin-walled sheath via the distal radial approach

    patients with coronary artery disease who planned to perform PCI using 7-Fr thin-walled sheath via the distal radial approach

    Procedure: Percutaneous coronary intervention via the distal radial approach

Interventions

  • ProcedurePercutaneous coronary intervention via the distal radial approach

    Percutaneous coronary intervention using a 7-Fr thin walled sheath (Prelude IDeal, MERIT MEDICAL, South Jordan, UT, USA) via the distal radial approach

06

What researchers measure

Primary outcomes

  1. Access site complication during hospitalization and within 1-month follow-up

    bleeding(defined by BARC criteria), hematoma (using modified EASY\[Early Discharge After Transradial Stenting of Coronary Arteries Study\] classification: A) Grade Ia hematoma was subclassified into 4 grades from the puncture site \[Grade 1, \<2cm; Grade2, 2-5cm; Grade3,\>5cm; and grade 4, hand swelling\], B) Grade Ib, wrist \< 5cm, C) Grade II, wrist \< 10cm, D) Grade III, forearm, E) Grade IV, upper arm), numbness, AV fistula, Pseudoaneurysm, and conventional and distal radial artery occlusion (assessed by manual palpation or ultrasonography\[prefer\])

    Time frame: Through procedure completion, up to 1month

  2. Success rate of PCI

    Success rate of PCI using 7-Fr sheath via the distal radial approach (%)

    Time frame: Through procedure completion, up to 1month

Secondary outcomes

  1. Hemostasis duration

    Hemostasis duration using 7-Fr thin-walled sheath via the distal radial approach (minute)

    Time frame: Through procedure completion, up to 24 hours

  2. Patency of proximal radial artery after hemostasis

    Patency of proximal radial artery using 7-Fr thin-walled sheath via the distal radial approach by ultrasonography after hemostasis (%)

    Time frame: Through procedure completion, up to 24 hours

  3. Patency of distal radial artery after 1 month

    Patency of distal radial artery using 7-Fr thin-walled sheath via the snuffbox approach by ultrasonography after 1-month (%)

    Time frame: Time Frame: up to 1month

Other outcomes

  1. If intravascular imaging modalities (OCT/IVUS) are seen during intervention, check for conventional radial radial artery complications through OCT/IVUS

    If intravascular imaging modalities (OCT/IVUS) are seen during intervention, check for conventional radial radial artery complications through OCT/IVUS

    Time frame: Through procedure completion

07

Study locations

2 sites
  • Yongin Severance Hospital
    Yongin, Gyeonggi-do 16995, South Korea
  • Yongin Severance Hospital
    Yongin, South Korea
08

References and documents

Publications

  • Roh JW, Lee OH, Heo SJ, Kim Y, Im E, Cho DK. Feasibility of percutaneous coronary intervention using a 7-French thin-walled sheath via the distal radial access. Sci Rep. 2025 May 15;15(1):16961. doi: 10.1038/s41598-025-01149-1. PubMed 40374669 ↗

Individual participant data

Plan to share: No — No planned

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05006027
Lead sponsor
Yonsei University
Collaborators
Severance Hospital, Merit Medical Systems, Inc.
Responsible party
Yongcheol Kim (Director head of snuffbox center in Yongin Severance Hospital, Principal Investigator, Clinical Professor, Yonsei University) — Principal investigator
First posted
Aug 16, 2021
Start date
Aug 16, 2021
Primary completion
Jul 17, 2024
Completion
Oct 15, 2024
Last update
Nov 25, 2025

Study contacts

Yongcheol Kim, MD
principal investigator · Yongin Severance Hopistal

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion